Allergy and Allergy Specialists
Allergy & Immunology
Dr. William R. Lumry, MD
|
|
Give Review
William R. Lumry is an expert in the field of Allergy & Immunology. He has 5 awards "Regional Top Doctor", "Fellow (FAAAAI)", "Whos Who in Medicine and Healthcare", "Top MD" and "Super Doctor". William Lumry has written publications. He has 62 publications published with PubMed. The lastest publication is: 'Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-bl...' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Safety and efficacy of C1 esterase inhibitor for Acute attacks in children with hereditary angioedema.
- Before and after, the impact of available on-demand treatment for HAE.
- Quality of life in patients with hereditary Angioedema receiving therapy for routine prevention of attacks.
- Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary Angioedema.
- Randomized controlled trial of ragweed Allergy immunotherapy tablet efficacy and safety in North American adults.
- Nanofiltered C1-esterase inhibitor for the Acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.
- Analysis of hereditary Angioedema attacks requiring a second dose of ecallantide.
- Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary Angioedema: Open-label continuation study.
- WAO Guideline for the Management of Hereditary Angioedema.
- Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary Angioedema attacks.
- Randomized placebo-controlled trial of the bradykinin B(2) receptor antagonist icatibant for the treatment of Acute attacks of hereditary angioedema: the FAST-3 trial.
- Hereditary Angioedema: A case of near fatal laryngeal swelling in a 41-year-old woman.
- Treatment of Laryngeal Hereditary Angioedema.
- The humanistic burden of hereditary Angioedema: Impact on health-related quality of life, productivity, and depression.
- Nanofiltered C1 inhibitor concentrate for treatment of hereditary Angioedema.
- Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent Asthma previously receiving ...
- Icatibant, a new bradykinin-receptor antagonist, in hereditary Angioedema.
- EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for Acute attacks of hereditary angioedema.
- Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal Allergic rhinitis.
- Roflumilast in symptomatic Chronic obstructive pulmonary disease: two randomised clinical trials.
- Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients.
- Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
- Critical role of kallikrein in hereditary Angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor.
- Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent Asthma.
- Medication compliance and disease exacerbation in patients with Asthma: a retrospective study of managed care data.
- Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal Allergic rhinitis.
- Desloratadine therapy for symptoms associated with perennial Allergic rhinitis.
- An otolaryngology, neurology, Allergy, and primary care consensus on diagnosis and treatment of sinus headache.
- Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
- Sinus headache: a neurology, otolaryngology, Allergy, and primary care consensus on diagnosis and treatment.
- Predicting response to omalizumab, an anti-IgE antibody, in patients with Allergic asthma.
- Omalizumab is effective in the long-term control of severe Allergic asthma.
- A comparison of once-daily triamcinolone acetonide aqueous and twice-daily beclomethasone dipropionate aqueous nasal sprays in the treatment of seasonal Allergic rhini...
- Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent Asthma.
- Improvement of aspirin-intolerant Asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
- Comparison of chromogenic and ELISA functional c1 inhibitor tests in diagnosing hereditary Angioedema.
- US Hereditary Angioedema Association Medical Advisory Board 2013 Recommendations for the Management of Hereditary Angioedema Due to C1 Inhibitor Deficiency.
- Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent Asthma.
- Aspirin-sensitive rhinoSinusitis: the clinical syndrome and effects of aspirin administration.
- Aspirin-sensitive asthma and rhinoSinusitis: current concepts and recent advances.
- Zomepirac sodium (Zomax) hypersensitivity in aspirin-sensitive Asthmatics.
- Aspirin-sensitive rhinoSinusitis asthma: a double-blind crossover study of treatment with aspirin.
- Acute and chronic desensitization of penicillin-allergic patients using oral penicillin.
- Adverse reactions to tartrazine.
- Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced Allergic rhinitis.
- Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic Asthma.
- Once-daily cetirizine effective in the treatment of seasonal Allergic rhinitis in children aged 6 to 11 years: a randomized, double-blind, placebo-controlled study.
- Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal Allergic rhinitis.
- Allergy-epitomes of progress: urticarial vasculitis.
- Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal Allergic rhinitis.
- Once daily fluticasone propionate is as effective for perennial Allergic rhinitis as twice daily beclomethasone diproprionate.
- Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed Allergic rhinitis: a placebo-controlled, double-blind study.
- Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial Rhinitis patients; a randomized, double-bl...
- Tri-Nasal triamcinolone acetonide nasal spray 200 and 400 micrograms qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 micrograms qd in patients...
- Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent Asthma.
- Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with Asthma.
- A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.
- Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent Asthma.
- Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of Asthma.
- Dose-ranging study of a new steroid for Asthma: mometasone furoate dry powder inhaler.
- A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of Allergic rhinitis.
Schools
University Of Texas Medical Branch At Galveston
Barnes Jewish Hospital Wash University
Scripps Clin Rsch Fdn
Procedures Preformed
- Allergy Shots
- Allergy Shots for Insect Stings
- Allergy Skin Testing
- Desensitization
- View All
Conditions Treated
- Acute Pharyngitis
- Acute Sinusitis
- Allergic Rhinitis
- Allergic Rhinitis Due to Food
- View All
Doctors Specialties
- Internal Medicine
- Allergy
- Immunology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerihealth
- Assurant Health
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Golden Rule
- GEHA
- Health Alliance
- HealthFirst
- HealthSmart
- Choice Care PPO
- Preferred PPO
- Mail Handlers Benefit Plan (MHBP)
- Managed Care (Non-HMO)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Old Surety Life Insurance CompanyMedicare MCR
- Principal Life
- Tricare
- UniCare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- Fellow (FAAAAI)
- Whos Who in Medicine and Healthcare
- Top MD
- Super Doctor
Education
-
Scripps Clinic -
Washington University - Barnes-Jewish Hospital -
Washington University -
University of Texas Medical Branch
Hospital
-
Medical City Dallas Hospital -
Texas Health Presbyterian Hospital Dallas
Drug Facts
| NPI NUMBER | 1598715914 | |
| NPPES Provider LastName | LUMRY | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 752314159 | |
| NPPES Provider State | TX | |
| Specialty Description | Allergy/Immunology | |
| Total Claim Count | 1766.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598715914 |
| Last Name Of The Provider | LUMRY |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
Dr. Keira N. Scanks, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tran H. Ly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bielose C. Konwe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dania A. Wierzbicki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew C. Lo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sonak B. Daulat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellen S. Sher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elliot J. Ginchansky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Neaville, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aasia I. Ghazi, MD
This Doctor is OpenDoctor Recommended.
|